Current Molecular Medicine
Title: Preface [Hot topic: HLA-B27 and Spondyloarthropathies Thirty Years Later (Executive Editor: Robert A. Colbert)]
Volume: 4 Issue: 1
Author(s): Robert A. Colbert
Affiliation:
Export Options
About this article
Cite this article as:
Colbert A. Robert, Preface [Hot topic: HLA-B27 and Spondyloarthropathies Thirty Years Later (Executive Editor: Robert A. Colbert)], Current Molecular Medicine 2004; 4 (1) . https://dx.doi.org/10.2174/1566524043479266
DOI https://dx.doi.org/10.2174/1566524043479266 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Pathogenetic Approach to Autoimmune Skin Disease Therapy: Psoriasis and Biological Drugs, Unresolved Issues, and Future Directions
Current Pharmaceutical Design The Long-Term Outcome of Juvenile Idiopathic Arthritis
Current Rheumatology Reviews Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design
Current Pharmaceutical Design Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Rheumatological Manifestations in Diabetes Mellitus
Current Diabetes Reviews Herbal Phytochemicals as Immunomodulators
Current Immunology Reviews (Discontinued) Cardiovascular Disease in the Rheumatic Diseases: How Systemic Inflammation May Contribute to Atherogenesis
Current Rheumatology Reviews Antifungal Therapy of Aspergillosis of the Central Nervous System and Aspergillus Endophthalmitis
Current Pharmaceutical Design Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) Efficacy of the Newest COX-2 Selective Inhibitors in Rheumatic Disease
Current Pharmaceutical Design Recent Advances in the Chemistry of Phthalimide Analogues and their Therapeutic Potential
Mini-Reviews in Medicinal Chemistry Pharmacogenetics, Target Molecules, and Biological Anti-Rheumatic Drugs in Autoimmune/Chronic Inflammatory Rheumatic Diseases
Current Pharmacogenomics Excess Cardiovascular Risk in Inflammatory Rheumatic Diseases: Pathophysiology and Targeted Therapy
Current Pharmaceutical Design Biologic Agents for Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Infections in the Pathogenesis of Autoimmune Diseases
Current Drug Targets - Inflammation & Allergy Novel Controlled Release Solid Dispersion for the Delivery of Diclofenac Sodium
Current Drug Delivery Ghrelin and Motilin in the Gastrointestinal System
Current Pharmaceutical Design Cytokines and their Antagonists as Therapeutic Agents
Current Medicinal Chemistry Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tissue-specific Glucocorticoid Signaling May Determine the Resistance Against Glucocorticoids in Autoimmune Diseases
Current Medicinal Chemistry